Clinical Trial: Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Effect of Rituximab in the Treatment of Resistant Ocular Inflammatory Lesions of Behcet's Disease (Pilot Study)

Brief Summary: The purpose of this study is to find if Rituximab can improve severe ocular lesions of Behcet's Disease.